In this Issue
By Robert L. Avery, MD, Associate Medical Editor, Allen C. Ho, MD, Chief Medical Editor
Pfizer is investing resources and scientific know-how to develop stem-cell therapies for retinal diseases.
By Jennifer Kreatsoulas, PHD, Senior Associate Editor
BUSINESS OF RETINA
By Darrell E. Baskin, MD; Chirag P. Shah, MD, MPH; and Jeremy D. Wolfe, MD
At Spectra Eye Institute, we strive toward the common goal of excellent patient care.
By Jan Amator, MBA
The BDOC, an ophthalmic professional organization in Germany, negotiates contracts with health insurance companies and advocates for governmental policies that affect its members.
With Armin Scharrer, MD
Rare complications of vitrectomy with small-gauge instrumentation can significantly affect vision.
By Susanne Binder, MD
By Aziz A. Khanifar, MD; Harry K. Roux, MD; and R.V. Paul Chan, MD
By Irina Belinsky, MD; Aparna Ramasubramanian, MD; Neelema Sinha, MD; and Carol Shields, MD
Implant technology offers promising solutions to the burden of repeated injections for retinal diseases.
By Szilard Kiss, MD
Novel formulations offer possibilities for efficacious therapies through topical routes.
By Daniel F. Kiernan, MD; and Jennifer I. Lim, MD
Standardized preparation may be a factor in low infection rate.
By Andrew A. Moshfeghi, MD, MBA
This molecule might enable earlier detection of neovascularization.
By Jayakrishna Ambati, MD
Current technologies include implanted and injected devices.
By Glenn J. Jaffe, MD
A review of the physiopathlology, epidemiology, diagnosis, and treatment for this rare condition.
By Hadas Newman, MD; and Paul T. Finger, MD
MEDICAL RETINA FEATURE
The complexity of this multifactorial disease state suggests a need for a tailored treatment approach.
By Seenu M. Hariprasad, MD; Veeral Sheth, MD; and Paulpoj Chiranand, MD
RETINAL IMAGING FEATURE
Imaging with FAF offers new insight into how and why GA progresses in some patients.
By Frank G. Holz, MD
Dr. Kaiser is a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine and a staff surgeon in the Vitreoretinal Department at the Cole Eye Institute, Cleveland Clinic. He is the Founding Director of the Digital Optical Coherence Tomography Reading Center (DOCTR) at the Cole Eye Institute.